Home › Research › Digital health tools
Integrative and interpretable framework to unveil the neurophysiological fingerprint of Alzheimer’s disease and mild cognitive impairment: A machine learning-SHAP approach
Víctor Gutiérrez-de Pablo, María Herrero-Tudela, Marina Sandonís-Fernández, Jesús Poza, Aarón Maturana-Candelas, Víctor Rodríguez-González, Miguel Ángel Tola-Arribas, Mónica Cano et al.. Journal of Applied Biomedicine, 2025-06-13
Topic: Amyloid, tau and blood-test diagnosis
Dementia and mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) are neurological pathologies associated with disruptions in brain electromagnetic activity, typically studied using magnetoencephalography (MEG) and electroencephalography (EEG). To quantify diverse brain properties, different families of parameters can be computed from MEG and EEG (i.e., spectral, non-linear, morphological, functional connectivity, or network structure and organisation). However, studying these characteristics separately overlooks the complex nature of brain activity. Integrative frameworks can be useful to unveil the intricate neurophysiological fingerprint, as well as to characterise pathological conditions comprehensively. To that purpose, data fusion methodologies are crucial, despite their interpretational challenges. In this study, Machine Learning (ML) models were trained to discriminate between groups of severity, whereas the SHapley Additive eXplanations (SHAP) algorithm was afterwards utilised to assess the relevance of the input characteristics into the output classification. Three databases were analysed: MEG (55 healthy controls, HC, 42 MCI patients, and 86 AD patients), EEG1 (51 HC, 52 MCI, and 100 AD), and EEG2 (45 HC, 69 MCI, and 82 AD). The best results for the three-class classification problem were obtained by Gradient Boosting for the MEG database: 3-class Cohen’s kappa coefficient of 0.5452 and accuracy of 72.63 %. Afterwards, using SHAP on Gradient Boosting, it has been shown that spectral features were identified as highly relevant across all databases. Furthermore, morphology measures presented high relevance for the MEG database, whereas EEG1 and EEG2 databases showed functional connectivity and multiplex organisation measures, respectively, as relevant subgroups of parameters. Finally, commonly relevant features across databases were selected using SHAP to generate the neurophysiological fingerprints of AD and MCI. This study highlights the relevance of different MEG and EEG parameters in characterising neurological pathologies. The proposed framework, based on MEG and EEG, can be used to generate interpretable, robust, and accurate neurophysiological fingerprints of AD and MCI.
Key findings
- Dementia and mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) are neurological pathologies associated with disruptions in brain electromagnetic activity, typically studied using magnetoencephalography (MEG) and electroencephalography (EEG).
- The best results for the three-class classification problem were obtained by Gradient Boosting for the MEG database: 3-class Cohen’s kappa coefficient of 0.5452 and accuracy of 72.63 %.
- Afterwards, using SHAP on Gradient Boosting, it has been shown that spectral features were identified as highly relevant across all databases.
Why it matters
This study trained machine learning models on brain electromagnetic data from MEG and EEG to tell apart healthy controls, people with mild cognitive impairment and people with Alzheimer's disease, with the best result reaching about 72.63% accuracy. It is a diagnostic classification study and does not test any treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Applied Biomedicine) |
| Journal's citation record | 1 / 4 | Journal of Applied Biomedicine: journal h-index 81 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 11 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 7.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 11 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Carlos Gómez: h-index 32 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Centro de Investigación Biomédica en Red: institution h-index 530 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
APA 7th
Pablo, V. G.-d., Herrero-Tudela, M., Sandonís-Fernández, M., Poza, J., Maturana-Candelas, A., Rodríguez-González, V., et al. (2025). Integrative and interpretable framework to unveil the neurophysiological fingerprint of Alzheimer’s disease and mild cognitive impairment: A machine learning-SHAP approach. Journal of Applied Biomedicine. https://doi.org/10.1016/j.bbe.2025.05.011
Vancouver
Pablo VG.-d, Herrero-Tudela M, Sandonís-Fernández M, Poza J, Maturana-Candelas A, Rodríguez-González V, et al. Integrative and interpretable framework to unveil the neurophysiological fingerprint of Alzheimer’s disease and mild cognitive impairment: A machine learning-SHAP approach. Journal of Applied Biomedicine. 2025. doi:10.1016/j.bbe.2025.05.011.
BibTeX
@article{pablo2025-0d3ba250,
author = {Pablo, Víctor Gutiérrez-de and Herrero-Tudela, María and Sandonís-Fernández, Marina and Poza, Jesús and Maturana-Candelas, Aarón and Rodríguez-González, Víctor and Tola-Arribas, Miguel Ángel and Cano, Mónica and others},
title = {{Integrative and interpretable framework to unveil the neurophysiological fingerprint of Alzheimer’s disease and mild cognitive impairment: A machine learning-SHAP approach}},
journal = {Journal of Applied Biomedicine},
year = {2025},
doi = {10.1016/j.bbe.2025.05.011},
url = {https://doi.org/10.1016/j.bbe.2025.05.011}
}
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.